Anida Pharma Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
2
Anida Pharma General Information
Description
Developer of a biopharmaceutical therapy designed for vision, hearing, and cognition. The company's platform specializes in a pipeline of treatments that target sensory organ dysfunction with an initial focus on unmet medical needs in pediatric patients, enabling the medical industry to prevent and restore neuro-sensory dysfunction.
Contact Information
Website
www.anidapharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
- 155 Brookline Street
- Suite 005
- Cambridge, MA 02139
- United States
+1 (617) 000-0000
Anida Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | Completed | Pre-Clinical Trials | ||||
| 2. Angel (individual) | 15-Oct-2015 | Cancelled | Pre-Clinical Trials | |||
| 1. Grant | 27-Sep-2013 | Completed | Pre-Clinical Trials |
Anida Pharma Patents
Anida Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| ES-2773310-T3 | Methods for treating ototoxicity | Active | 28-Feb-2013 | 0000000000 | |
| US-9468620-B2 | Methods of treating ototoxicity | Inactive | 28-Feb-2013 | 0000000000 | 0 |
| US-20160000742-A1 | Methods of treating ototoxicity | Active | 28-Feb-2013 | 0000000000 | 0 |
| US-9987244-B2 | Methods of treating ototoxicity | Active | 28-Feb-2013 | 0000000000 | 00 |
| US-20170105957-A1 | Methods of treating ototoxicity | Active | 28-Feb-2013 | A61K31/202 |
Anida Pharma Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Per Gjorstrup Ph.D | Founder, President & Chief Executive Officer |
Anida Pharma Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Michael J. Fox Foundation | Limited Partner | 000 0000 | 000000 0 | ||
| CH Innovations | Venture Capital | Minority | 000 0000 | 000000 0 |